2003. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: Comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry
74, 1215–20., , , et al.
2008. Neuropathology of hippocampal sclerosis. Handb Clin Neurol
89, 569–72. and .
2002. Parkinson disease neuropathology: Later-developing dementia and loss of the levodopa response. Arch Neurol
59, 102–12., , , et al.
2009. Non-fluent speech in frontotemporal lobar degeneration. J Neuroling
22, 370–83., , , et al.
2008. DTI analysis of white matter deficits in frontotemporal lobar dementia. Neurology
70, A452., , , et al.
2006. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology
67, 1931–4., , , et al.
2004. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects. Neuroimage
23, 325–35., , , et al.
2000. MRI volumetric study of dementia with Lewy bodies: A comparison with AD and vascular dementia. Neurology
54, 1304–9., , , et al.
2008. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain
131, 706–20., , , et al.
2007. Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation. Neurobiol Aging
30, 752–8., , , et al.
2007. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology
69, 747–54., , , et al.
2008. CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology
70, 1827–35., , , et al.
1992. Corticobasal degeneration: Decreased and asymmetrical glucose consumption as studied with PET. Mov Disord
7, 348–54., , , et al.
2003. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol
54 (Suppl 5), S15–9., , , et al.
2004. L-dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia. Neurology
63, 376–8., , , et al.
2007. Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia. Arch Neurol
64, 246–51., , , et al.
2006. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol
63, 81–6., , , et al.
2008. Longitudinal studies of semantic dementia: The relationship between structural and functional changes over time. Neuropsychologia
46, 2177–88., , , et al.
2003. Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study. Mov Disord
18, 884–9., , , et al.
2002. Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage
17, 618–30., , , et al.
2004. Cerebral atrophy in Parkinson's disease with and without dementia: A comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain
127, 791–800., , , et al.
2007. Left inferior parietal representations for skilled hand-object interactions: Evidence from stroke and corticobasal degeneration. Cortex
43, 411–23., , , et al.
1992. Asymmetric cortical degenerative syndromes: Clinical and radiologic correlations. Neurology
42, 1462–8., , , et al.
2005. A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology
65, 75–80., , , et al.
2007. Patterns of white matter atrophy in frontotemporal lobar degeneration. Arch Neurol
64, 1619–24., , , et al.
2008. Overlap in frontotemporal atrophy between normal aging and patients with frontotemporal dementias. Alzheimer Dis Assoc Disord
22, 327–35., , , et al.
2006. Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol
60, 677–87., , , et al.
2005. Fluent versus nonfluent primary progressive aphasia: A comparison of clinical and functional neuroimaging features. Brain Lang
94, 54–60., , , et al.
2004. The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease. Neuroimage
23, 956–66., , , et al.
2006. In vivo SPECT imaging of muscarinic acetylcholine receptors using (R, R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia. Neuroimage
33, 423–9., , , et al.
2005. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT. Eur J Nucl Med Mol Imaging
32, 1176–85., , , et al.
2003. Lewy body cortical involvement may not always predict dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry
74, 852–6., , , et al.
2003. Neural basis for sentence comprehension deficits in frontotemporal dementia. Brain Lang
85, 211–21., , , et al.
2008. Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI. Neuroimage
41, 1220–7., , , et al.
2008. The neural basis of semantic memory: Evidence from semantic dementia. Neurobiol Aging
30, 2043–52., , , et al.
2005. Measures of brain morphology and infarction in the Framingham heart study: Establishing what is normal. Neurobiol Aging
26, 491–510., , , et al.
2008. Regional white matter pathology in mild cognitive impairment: Differential influence of lesion type on neuropsychological functioning. Stroke
39, 794–9., , , et al.
2007. Anatomical and functional alterations in semantic dementia: A voxel-based MRI and PET study. Neurobiol Aging
28, 1904–13., , , et al.
2001. Neuropathology of Pick's disease. Neurology
56 (11 Suppl 4), S16–20..
2008. Neuropathology of progressive supranuclear palsy. Handb Clin Neurol
2002. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol
61, 935–46., , , et al.
1997. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. Eur J Nucl Med
24, 320–5., , , et al.
1998. Intellectual, mnemonic, and frontal functions in dementia with Lewy bodies: A comparison with early and advanced Parkinson's disease. Behav Neurol
11, 173–83., , , et al.
2008. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease. Neuroimage
39, 619–33., , , et al.
2005. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage
26, 912–21., , , et al.
2005. How useful is [123I]beta-CIT SPECT in clinical practice?
J Neurol Neurosurg Psychiatry
76, 1211–6., , , et al.
1991. The metabolic landscape of cortico-basal ganglionic degeneration: Regional asymmetries studied with positron emission tomography. J Neurol Neurosurg Psychiatry
54, 856–62., , , et al.
1998. Neuropathology of white matter changes in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord
9 (Suppl 1), 6–12..
2002. Neuropathology of white matter lesions in vascular cognitive impairment. Cerebrovasc Dis
13 (Suppl 2), 11–5..
2006. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol
59, 512–9., , , et al.
2000. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology
55, 1626–35., , , et al.
2005. Longitudinal study of cerebral blood flow SPECT in Parkinson's disease with dementia, and dementia with Lewy bodies. Int J Geriatr Psychiatry
20, 776–82., , , et al.
2003. Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage
20, 1309–19., , , et al.
2006a. Frontotemporal dementia: clinicopathological correlations. Ann Neurol
59, 952–62., , , et al.
2006b. Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J Neuropathol Exp Neurol
65, 571–81., , , et al.
2007. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain
130, 2616–35., , , et al.
2008. MR imaging of familial Creutzfeldt-Jakob disease: A blinded and controlled study. Am J Neuroradiol
29, 1638–43., , , et al.
2000. Semantic dementia: Clinical, radiological and pathological perspectives. J Neurol
247, 409–22. and .
2008. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt–Jakob disease. Arch Neurol
65, 1341–6., , , et al.
2008. Pathological TDP-43 in parkinsonism–dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol
115, 133–45., , , et al.
2007. Identification of Alzheimer and vascular lesion thresholds for mixed dementia. Brain
130, 2830–6., , , et al.
2008. The logopenic/phonological variant of primary progressive aphasia. Neurology
71, 1227–34., , , et al.
2004. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol
55, 335–46., , , et al.
2008. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: The Leukoaraiosis and Disability study. Stroke
39, 1414–20., , , et al.
2004. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Neuroimage
21, 714–24., , , et al.
2001. Perfusion fMRI using arterial spin labeling in Alzheimer's disease and frontotemporal dementia: Correlations with language. Brain Lang
79, 94–5., , , et al.
2002. Sentence processing strategies in healthy seniors with poor comprehension: An fMRI study. Brain Lang
80, 296–313., , , et al.
1996a. Language comprehension profiles in Alzheimer's disease, multi-infarct dementia, and frontotemporal degeneration. Neurology
47, 183–9., , , et al.
2004. What's in a name: Voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration. Brain
127, 628–49., , , et al.
1996b. Progressive nonfluent aphasia: language, cognitive, and PET measures contrasted to probable Alzheimer's disease. J Cogn Neurosci
8, 135–54., , , et al.
2005. A longitudinal study of sentence comprehension difficulty in primary progressive aphasia. J Neurol Neurosurg Psychiatry
76, 644–9. and .
1998. Language comprehension and regional cerebral defects in frontotemporal degeneration and Alzheimer's disease. Neurology
50, 157–63., , , et al.
2007. TDP-43 pathologic lesions and clinical phenotype in frontotemporal lobar degeneration with ubiquitin-positive inclusions. Arch Neurol
64, 1449–54., , , et al.
2008. Longitudinal decline in autopsy-defined frontotemporal lobar degeneration. Neurology
70, 2036–45., , , et al.
2002. Chromosome 3 linked frontotemporal dementia (FTD-3). Neurology
59, 1585–94., , , et al.
2003. Calculation impairment in neurodegenerative diseases. J Neurol Sci
208, 31–8., , , et al.
2004. Dissociation of numbers and objects in corticobasal degeneration and semantic dementia. Neurology
62, 1163–9., , , et al.
2001. Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol
102, 355–63. and .
1998. Medial temporal and whole-brain atrophy in dementia with Lewy bodies: A volumetric MRI study. Neurology
51, 357–62., , , et al.
2000. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies. Exp Neurol
162, 247–56., , , et al.
2004. Clinicopathological correlates in frontotemporal dementia. Ann Neurol
56, 399–406., , , et al.
2005. MRI correlates of alien leg-like phenomenon in corticobasal degeneration. Mov Disord
20, 870–3., , , et al.
2008. Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease. Acta Neuropathol
116, 215–20., , , et al.
2006. Cognitive impairment and celiac disease. Arch Neurol
63, 1440–6., , , et al.
2009a. Alzheimer disease and corticobasal degeneration presenting as corticobasal syndrome. Mov Disord
24, 1375–9., , , et al.
2009b. Survival profiles of patients with frontotemporal dementia and motor neuron disease. Arch Neurol
66, 1359–64., , , et al.
1998a. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology
51, 125–30., , , et al.
1998b. Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med
39, 1875–8., , , et al.
1999. Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology
53, 413–6., , , et al.
2007. Neurofibrillary tangle-predominant dementia: Comparison with classical Alzheimer disease. Acta Neuropathol
113, 107–17. and .
1999. Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol
56, 1233–9., , , et al.
2006a. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain
129, 1385–98., , , et al.
2005. Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND. Neurology
65, 645–7., , , et al.
2006b. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology
66, 41–8., , , et al.
2004. Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. Arch Neurol
61, 1881–4., , , et al.
2008a. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging
29, 280–9., , , et al.
2008b. Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology
70, 25–34., , , et al.
2008c. Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology
70, 1850–7., , , et al.
2008. Creutzfeldt–Jakob disease: Which diffusion-weighted imaging abnormality is associated with periodic EEG complexes?
255, 1411–4., , , et al.
1991. Primary progressive non-fluent aphasia: A case study. Cortex
27, 121–9., , , et al.
2005. The evolution and pathology of frontotemporal dementia. Brain
128, 1996–2005., , , et al.
2007. Patterns of MRI atrophy in tau positive and ubiquitin positive frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry
78, 1375–8., , , et al.
2002. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. Mov Disord
17, 303–12., , , et al.
2000. Corticobasal degeneration: Evaluation of cortical atrophy by means of hemispheric surface display generated with MR images. Radiology
216, 31–8., , , et al.
2006. Clinical and pathological characterization of progressive aphasia. Ann Neurol
59, 156–65., , , et al.
2004. The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology
62, 506–08., , , et al.
1993. Is the incidence of dementing illness changing? A 25-year time trend study in Rochester, Minnesota (1960–1984). Neurology
43, 1887–92., , , et al.
2007. Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia. Neurology
68, 927–31., ., , et al.
2007. Brain imaging and neuropsychology in late-onset dementia due to a novel mutation (R93C) of valosin-containing protein. Clin Neuropathol
26, 232–40., , , et al.
1996. Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study. Neurology
46, 678–81., , , et al.
1999. Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration. J Neurol
246, 1151–8., , , et al.
2008. Phenotype variability in progranulin mutation carriers: A clinical, neuropsychological, imaging and genetic study. Brain
131, 732–46., , , et al.
2004. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: Phenotype and suggestive mapping of the DM3 locus to chromosome 15q21–24. Brain
127, 1979–92., , , et al.
2008. Linking MRI hyperintensities with patterns of neuropsychological impairment: Evidence for a threshold effect. Stroke
39, 806–13., , , et al.
2007. DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers. Neurology
68, 812–9., , , et al.
2009. Neuropsychological patterns in MRI-defined subgroups of patients with degenerative dementia. J Int Neuropsychol Soc, 15, 459–70., , , et al.
2003. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord
18, 467–86., , , et al.
2001. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology
56, 643–9., , , et al.
2000. Contribution of PET studies in diagnosis of corticobasal degeneration. Eur Neurol
44, 12–21., , , et al.
2003. Sporadic Creutzfeldt–Jakob disease mimicking variant Creutzfeldt–Jakob disease. Arch Neurol
60, 767–70., , , et al.
2008. Patient care and management of frontotemporal lobar degeneration. Am J Alzh Dis Other Dementias
23, 125–31. and .
2007. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: A phase III, multicentre study. Lancet Neurol
6, 305–13., , , et al.
2005. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology
65, 1863–72., , , et al.
1996. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology
47, 1113–24., , , et al.
2001. Clinical and pathological diagnosis of frontotemporal dementia: Report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol
58, 1803–09., , , et al.
2006. Variations in regional SPECT hypoperfusion and clinical features in frontotemporal dementia. Neurology
66, 517–22., , , et al.
2007. Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease. J Neurol Neurosurg Psychiatry
78, 350–5., , , et al.
2008. Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt–Jakob disease. Am J Neuroradiol
29, 1519–24., , , et al.
2007. Accuracy of the clinical evaluation for frontotemporal dementia. Arch Neurol
64, 830–5., , , et al.
2008. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol
63, 709–19., , , et al.
2007. Vascular factors predict rate of progression in Alzheimer disease. Neurology
69, 1850–8., , , et al.
2001. Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation. Ann Neurol
50, 358–65., , , et al.
1997. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol
42, 85–94., , , et al.
2007. Symmetric temporal abnormalities on MR imaging in amyotrophic lateral sclerosis with dementia. Am J Neuroradiol
28, 1511–6., , , et al.
2008. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med
49, 390–8., , , et al.
2006. Characteristics of visual hallucinations in Parkinson disease dementia and dementia with Lewy bodies. Am J Geriatr Psychiatry
14, 153–60., , , et al.
2006. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol
60, 314–22., , , et al.
2000. A voxel-based morphometry study of semantic dementia: Relationship between temporal lobe atrophy and semantic memory. Ann Neurol
47, 36–45., , , et al.
2001. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology
57, 2229–35., , , et al.
2007. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol
64, 530–4., , , et al.
2007. Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology
68, 1274–83., , , et al.
1998. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology
51, 1546–54., , , et al.
2006. Declarative memory impairments in Alzheimer's disease and semantic dementia. Neuroimage
30, 1010–20., , , et al.
2003. Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain
126, 2406–18., , , et al.
2006. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science
314, 130–3., , , et al.
2000. Regional cerebral distribution of [Tc-99m] hexylmethylpropylene amineoxine in patients with progressive aphasia. J Neuroimaging
10, 162–8., , , et al.
2004. Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Mov Disord
19, 60–7., , , et al.
2004. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol
61, 919–25., , , et al.
2005. Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies. Psychiatry Res
139, 79–88., , , et al.
2005. Three-dimensional stereotactic surface projection SPECT analysis in Parkinson's disease with and without dementia. Mov Disord
20, 999–1005., , , et al.
1996. Molecular basis of phenotypic variability in sporadic Creutzfeldt–Jakob disease. Ann Neurol
39, 767–78., , , et al.
2001. Neural and cognitive bases of upper limb apraxia in corticobasal degeneration. Neurology
57, 1259–68., , , et al.
2007. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol
6, 994–1003., , , et al.
2005. Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: Study on 72 patients. J Neural Transm
112, 677–92., , , et al.
2005. Subcortical vascular dementia: Integrating neuropsychological and neuroradiologic data. Neurology
65, 376–82., , , et al.
1997. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke
28, 1158–64., , , et al.
1994. Human prion diseases. Ann Neurol
35, 385–95. and .
2007. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology
68, 1205–12., , , et al.
2004. Right and left medial orbitofrontal volumes show an opposite relationship to agreeableness in FTD. Dement Geriatr Cogn Disord
17, 328–32., , , et al.
2001. Verb comprehension in frontotemporal degeneration: The role of grammatical, semantic and executive components. Neurocase
7, 173–84., , , et al.
1998. Hippocampal atrophy is related to impaired memory, but not frontal functions in non-demented Parkinson's disease patients. Neuroreport
9, 1507–11., , , et al.
2008. Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene. Arch Neurol
65, 506–13., , , et al.
1993. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology
43, 250–60., , , et al.
2006. Behavioral features in semantic dementia vs other forms of progressive aphasias. Neurology
67, 1752–6., , , et al.
2002a. Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology
58, 198–208., , , et al.
2002b. Emotion comprehension in the temporal variant of frontotemporal dementia. Brain
125, 2286–95., , , et al.
2007. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt–Jakob disease. Dement Geriatr Cogn Disord
24, 207–12., , , et al.
2007. Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol
62, 59–66., , , et al.
2005. The natural history of temporal variant frontotemporal dementia. Neurology
64, 1384–90., , , et al.
2005. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet
37, 806–08., , , et al.
2007. Frontotemporal lobar degeneration: Clinical and pathological relationships. Acta Neuropathol
114, 31–8., , , et al.
1997. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA
277, 813–7., , , et al.
1999. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology
53, 502–07., , , et al.
2008. Independent cognitive effects of atrophy and diffuse subcortical and thalamico-cortical cerebrovascular disease in dementia. Stroke
39, 822–30., , , et al.
1986. Foci of MRI signal (pseudo lesions) anterior to the frontal horns: Histologic correlations of a normal finding. Am J Roentgenol
147, 331–7., , , et al.
1995. The contribution of single photon emission tomography to the clinical differentiation of degenerative cortical brain disorders. J Neurol
242, 579–86., , , et al.
2005. Temporal lobe atrophy on MRI in Parkinson disease with dementia: A comparison with Alzheimer disease and dementia with Lewy bodies. Neurology
64, 861–5., , , et al.
1997. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain
120, 1541–52., , , et al.
1996. Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia. Ann Neurol
39, 166–73., , , et al.
2008. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum Mol Genet
17, 313–22., , , et al.
2007. Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol
17, 63–73. and .
1997. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. J Nucl Med
38, 797–802., , , et al.
2002. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke
33, 21–5., , , et al.
2008. Inclusion body myopathy, Paget's disease of the bone and frontotemporal dementia: Recurrence of the VCP R155H mutation in an Italian family and implications for genetic counselling. Clin Genet
74, 54–60., , , et al.
1999. In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies. Lancet
354, 646–7., , , et al.
2002. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry
73, 134–40., , , et al.
2007. Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. Clin Genet
72, 420–6., , , et al.
2007a. Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations. Arch Neurol
64, 371–6., , , et al.
2007b. Rates of cerebral atrophy differ in different degenerative pathologies. Brain
130, 1148–58., , , et al.
2005. Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia. Arch Neurol
62, 1402–08., , , et al.
2004. Voxel-based morphometry in tau-positive and tau-negative frontotemporal lobar degenerations. Neurodegener Dis
1, 225–30., , , et al.
2007c. Focal atrophy in dementia with Lewy bodies on MRI: A distinct pattern from Alzheimer's disease. Brain
130, 708–19., , , et al.
2000. Diagnosis of new variant Creutzfeldt–Jakob disease. Ann Neurol
47, 575–82., , , et al.
2007. Binge eating is associated with right orbitofrontal–insular–striatal atrophy in frontotemporal dementia. Neurology
69, 1424–33., , , et al.
2007. Reversal of the concreteness effect for verbs in patients with semantic dementia. Neuropsychology
21, 9–19., , , et al.
2007. A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies. Eur J Neurol
14, 1357–62., , , et al.
2008. Apathy and disinhibition in frontotemporal dementia: Insights into their neural correlates. Neurology
71, 736–42., , , et al.
2000. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt–Jakob disease. Lancet
355, 1412–8., , , et al.